NDC11 31722075610
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 31722-0756-10 | 31722-0756 |
| 31722-756-10 | 31722-756 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Camber Pharmaceuticals, Inc. | cdf59426-2a2f-4a60-943a-e6cef3eb31e1 | 2026-06-09 | Boxed warning, Warnings, Adverse reactions | 31722-756-10 31722-756 31722075610 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.